2-(2,3-Difluoro-phenyl)-1H-imidazo[4,5-c]pyridine, 97.0%, 100mg

N,N-Diethylaniline>99.0%(GC)(T)500mL

5-chloro-3-(trichloromethyl)-1,2,4-thiadiazole, 95.0%, 2g

1-Fluoro-4-(prop-2-yn-1-yloxy)benzene, 95%, 100mg

3-Amino-7,9-difluoro-1,3,4,5-tetrahydro-1-benzazepin-2-one, 98%, 250mg

2-Bromo-4-methylnicotinonitrile, 95.0%, 100mg

1-Boc-4-(3-Amino-6-bromopyrazin-2-yl)piperazine, 95.0%, 250mg

Récipient de réaction à bride plate, cylindrique, gradué, avec enveloppe de trempe et de vide et vanne de vidange, DN 60, 500 ml, 160 mm, 1 pièce

N-[Bis(methylthio)methylene]-p-toluenesulfonamide>97.0%(HPLC)(N)5g

Ethylmorpholine-2-carboxylate, 95.0%, 1g

TERT-BUTYL (5-METHYLPIPERIDIN-3-YL)CARBAMATE, 95.0%, 500mg

1-Chloroethyl chloroformate, 98.0%, 25g

meso-Tetraphenylporphyrin, >99%, 10g